Florida’s dengue surge is changing the fever differential for primary care and emergency teams
Florida physicians can no longer assume that dengue belongs only in the travel medicine file. In parts of the state, especially Hillsborough County, a febrile patient who has never left Florida may still have mosquito-borne dengue, and that change carries immediate diagnostic and public health consequences. The Florida Department of Health counted 425 locally acquired dengue cases this year from 11 counties, including 57 reported in the week of Oct. 11-17. Hillsborough County alone accounted for 346 cases, about 81% of the statewide total.
The clinical meaning is straightforward: travel history still matters, but it is no longer a reliable gatekeeper in Florida. Fever, headache, retro-orbital pain, myalgias, arthralgias, and rash now deserve a dengue workup even when the patient has not crossed a state line. In a region where Aedes mosquitoes are established, local transmission alters pretest probability enough to change bedside decision-making.
One sentence now matters in the exam room: a negative travel history does not rule out dengue.
Local transmission has reached a scale Florida has not seen in decades
This year’s tally dwarfs Florida’s recent local dengue history. The state recorded 62 locally acquired cases in all of 2025, and its previous high was 199 local cases in 2023. Of 395 locally acquired cases typed by polymerase chain reaction testing, 393 were dengue virus serotype 2 and two were serotype 3. Public health investigators also identified dengue virus serotype 2 in 20 pools of Aedes aegypti mosquitoes, 19 in Hillsborough County and one in Pasco County.
The serotype pattern matters clinically because DENV-2 can signal intense transmission within a mosquito-human cycle that is already established. Once an arbovirus is circulating locally in vectors and humans, every untreated febrile patient becomes part of a larger containment problem. The state confirmed its first dengue-related death of the year on Sept. 18 in Hillsborough County; the patient was an elderly Tampa woman who died Sept. 4.
Across the state, the outbreak has not been confined to one corner of the map. Pinellas County reported 51 local cases, while Miami-Dade had nine, Orange eight, Pasco four, Citrus two, and Brevard, Broward, Manatee, Palm Beach, and Polk counties one each. Seminole County confirmed a locally acquired case after the latest state report cutoff, on Oct. 21.
Testing must track the illness clock, not clinician convenience
Dengue testing works best when symptom timing is built into the order set. During the first seven days of illness, the preferred approach is a nucleic acid amplification test, such as reverse transcription PCR, combined with an IgM antibody test. An NS1 antigen test plus IgM is an alternative during that early phase. After day seven, IgM becomes the primary test. Serum remains the preferred specimen.
A negative NAAT or NS1 result does not exclude infection. That warning is especially important when fever begins in a county with documented local transmission and mosquito activity remains high. Testing is available through most state health departments and commercial laboratories, but treatment should not wait for confirmation when the clinical picture fits dengue.
The biological reason is simple: viremia and antigenemia peak early, then wane as the immune response rises. Miss that window and the laboratory signal fades even while the patient remains at risk for plasma leakage or bleeding. This is why CDC guidance advises clinicians to provide appropriate management without waiting for test results when dengue is suspected.
Warning signs separate outpatient dengue from hospital-level disease
The critical phase of dengue typically falls three to eight days after fever begins, often when the fever is improving and the patient appears deceptively better. That is when warning signs can surface, and they should be checked at every encounter. Severe abdominal pain or tenderness, persistent vomiting, pleural effusion or ascites, mucosal bleeding, altered mental status, liver enlargement of at least 2 centimeters, and a progressive rise in hematocrit all point toward progression to severe dengue.
Patients with warning signs should be managed in the hospital. Outpatient care is appropriate only for those without warning signs who remain hemodynamically stable and can tolerate oral fluids. Acetaminophen is recommended for fever; aspirin and nonsteroidal anti-inflammatory drugs should be avoided because of bleeding risk. Regular follow-up, ideally daily, and complete blood counts as indicated are part of safe ambulatory care.
Older adults warrant particular caution. CDC guidance advises considering inpatient care for patients older than 65 and for some with chronic conditions. In practice, that means lower thresholds for observation, repeat examination, and laboratory reassessment in patients who might decompensate quickly once capillary leak begins.
Reporting is part of treatment when dengue is circulating locally
Florida law requires practitioners to report diseases of public health significance to the Department of Health, and dengue fever is on the state’s practitioner reportable disease list. County health departments receive those reports. The CDC adds that all suspected cases should be reported because dengue is nationally notifiable.
That reporting step is not bureaucratic housekeeping. It feeds vector control, cluster detection, and contact with patients in neighborhoods where transmission may still be active. In Hillsborough County, local officials declared a state of local emergency on Sept. 24 to accelerate mosquito-control spending, and Hillsborough and Pinellas counties have extended their declarations through Oct. 29.
Household prevention also matters after the visit ends. To reduce onward spread, the CDC advises the patient sleep under a bed net and the household use Environmental Protection Agency-registered repellent for three weeks.
Travel importation is still seeding the state’s outbreaks
Florida has also logged 320 travel-associated dengue cases in 2026, including 266 linked to Cuba and 200 reported in Miami-Dade County. Those numbers reinforce a familiar arboviral pattern: imported infections can reintroduce virus into mosquito-rich communities, where local transmission can then expand. The state health department notes that frequent travel makes reintroduction possible.
Health officials also believe the current count underestimates true infection burden, because many dengue infections are asymptomatic or mild enough never to enter care. Cooler, drier fall weather may slow mosquito activity, but any reduction in case counts is likely to lag behind the weather change. Michael von Fricken, an associate professor of environmental and global health at the University of Florida, said dengue’s threat in Florida is unlikely to tail off while the mosquitoes that carry it remain abundant.
For clinicians, the practical shift is already here. Febrile illness in Florida now demands a dengue differential even without travel, and the ordering, counseling, and reporting steps need to follow.